Zdrowie i gospodarka · 13/04/2011

FDA Requests Public Comment on Proposed Collection of Information for Fast Track Drug Development Programs

The FDA is seeking public input on a proposed collection of information related to fast track drug development programs, which would require sponsors and applicants to submit specific information for review and approval.